NASDAQ : STIM

Neuronetics, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.44M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Neuronetics, Inc. (STIM) reported revenue of 155.10M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue155.10M149.16M74.89M71.35M65.21M55.31M
Cost of Revenue78.51M76.45M20.13M17.74M15.48M11.65M
Gross Profit76.59M72.71M54.76M53.60M49.72M43.66M
Selling, General & Admin93.18M97.16M75.95M72.74M75.50M63.30M
Research & Development5.87M6.58M12.77M9.52M9.34M7.92M
Operating Expenses99.05M103.74M88.72M82.26M84.83M71.22M
Operating Income-22.46M-31.04M-33.96M-28.65M-35.11M-27.56M
Interest Expense-8.91M-8.41M-7.29M-5.42M-4.25M-4.02M
Interest & Investment Income1.46M716.00K2.55M5.79M2.20M200.00K
Other Non Operating Income (Expenses)190.00K
EBT Excluding Unusual Items-29.91M-38.73M-38.70M-28.29M-37.16M-31.19M
Asset Writedown-400.00K-400.00K-600.00K-1.90M
Other Unusual Items-539.00K-4.43M
Pretax Income-30.85M-39.13M-43.73M-30.19M-37.16M-31.19M
Earnings From Continuing Operations-30.85M-39.13M-43.73M-30.19M-37.16M-31.19M
Minority Interest in Earnings419.00K137.00K19.00K
Net Income-30.43M-39.00M-43.71M-30.19M-37.16M-31.19M
Net Income to Common-30.43M-39.00M-43.71M-30.19M-37.16M-31.19M
Shares Outstanding (Basic)69.72M65.95M31.73M28.66M26.90M25.48M
Shares Outstanding (Diluted)69.72M65.95M31.73M28.66M26.90M25.48M
EPS (Basic)-0.44-0.59-1.38-1.05-1.38-1.22
EPS (Diluted)-0.44-0.59-1.38-1.05-1.38-1.22
Free Cash Flow-11.25M-21.18M-32.46M-34.41M-34.01M-30.34M
Free Cash Flow Per Share-0.16-0.32-1.02-1.20-1.26-1.19
Gross Margin49.38%48.75%73.12%75.13%76.25%78.93%
Operating Margin-14.48%-20.81%-45.35%-40.16%-53.85%-49.83%
Profit Margin-19.62%-26.15%-58.36%-42.31%-56.99%-56.39%
Free Cash Flow Margin-7.25%-14.20%-43.35%-48.22%-52.15%-54.84%
EBITDA-19.26M-27.63M-31.98M-26.74M-33.56M-26.55M
EBITDA Margin-12.42%-18.52%-42.70%-37.48%-51.47%-48.01%
D&A For EBITDA3.20M3.40M1.98M1.92M1.55M1.01M
EBIT-22.46M-31.04M-33.96M-28.65M-35.11M-27.56M
EBIT Margin-14.48%-20.81%-45.35%-40.16%-53.85%-49.83%
Revenue as Reported155.10M149.16M74.89M71.35M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents19.20M28.13M18.46M59.68M70.34M94.14M
Cash & Short-Term Investments19.20M28.13M18.46M59.68M70.34M94.14M
Accounts Receivable16.19M16.69M23.56M16.69M15.13M9.90M
Other Receivables2.90M2.90M
Receivables16.50M17.12M27.39M21.64M15.36M9.98M
Inventory5.50M4.33M4.25M8.09M8.90M6.56M
Prepaid Expenses3.50M2.92M3.95M1.87M2.17M3.09M
Restricted Cash5.75M6.00M1.00M
Other Current Assets2.77M3.05M3.08M2.51M2.00M1.56M
Total Current Assets53.23M61.55M58.12M93.79M98.77M115.33M
Property, Plant & Equipment27.38M28.03M33.34M4.78M5.32M5.10M
Goodwill23.62M23.62M18.63M
Other Intangible Assets18.92M18.95M20.01M4.20M3.60M2.50M
Long-Term Accounts Receivable65.00K98.00K86.00K661.00K1.22M1.70M
Long-Term Deferred Charges6.98M7.97M8.90M8.37M7.57M6.76M
Other Long-Term Assets1.29M1.18M1.52M230.00K45.00K-282.00K
Total Assets131.53M141.55M140.90M115.83M116.88M141.22M
Accounts Payable12.42M10.74M11.08M4.75M2.43M4.30M
Accrued Expenses8.73M12.14M12.59M12.38M14.51M7.93M
Current Portion of Long-Term Debt13.12M
Current Portion of Leases5.14M5.56M4.79M845.00K824.00K670.00K
Current Unearned Revenue1.14M753.00K974.00K1.62M1.98M2.50M
Other Current Liabilities872.00K1.33M1.84M213.00K328.00K306.00K
Total Current Liabilities28.31M30.52M31.27M19.81M33.20M15.70M
Long-Term Debt61.52M65.81M55.15M59.28M22.83M35.34M
Long-Term Leases19.86M18.93M22.69M2.35M2.97M3.54M
Long-Term Unearned Revenue58.00K48.00K2.00K200.00K829.00K1.47M
Other Long-Term Liabilities142.00K
Total Liabilities109.89M115.31M109.10M81.64M59.82M56.05M
Common Stock762.00K690.00K557.00K291.00K273.00K264.00K
Additional Paid-In Capital490.24M480.48M446.94M409.98M402.68M393.64M
Retained Earnings-473.15M-458.79M-419.79M-376.08M-345.89M-308.73M
Total Common Equity17.85M22.38M27.71M34.19M57.06M85.17M
Minority Interest3.79M3.86M4.09M
Shareholders' Equity21.64M26.24M31.80M34.19M57.06M85.17M
Total Liabilities & Equity131.53M141.55M140.90M115.83M116.88M141.22M
Total Debt86.52M90.30M82.63M62.47M39.74M39.54M
Net Cash (Debt)-67.33M-62.17M-64.17M-2.80M30.59M54.60M
Net Cash Per Share-0.97-0.94-2.02-0.101.142.14
Filing Date Shares Outstanding76.20M69.28M65.81M29.76M28.36M26.63M
Total Common Shares Outstanding76.19M68.99M55.68M29.09M27.27M26.39M
Working Capital24.92M31.03M26.86M73.98M65.57M99.63M
Book Value Per Share0.230.320.501.182.093.23
Tangible Book Value-24.69M-20.19M-10.93M29.99M53.46M82.67M
Tangible Book Value Per Share-0.32-0.29-0.201.031.963.13
Machinery5.76M6.75M7.28M2.85M3.07M3.29M
Leasehold Improvements1.49M1.61M1.61M1.44M1.44M471.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-30.43M-39.00M-43.71M-30.19M-37.16M-31.19M
Depreciation & Amortization3.13M3.46M2.07M2.01M1.65M1.06M
Loss (Gain) From Sale of Assets398.00K72.00K28.00K
Asset Writedown & Restructuring Costs3.96M
Stock-Based Compensation5.96M6.85M5.60M7.32M8.75M7.87M
Provision & Write-off of Bad Debts344.00K587.00K2.06M390.00K341.00K763.00K
Other Operating Activities1.25M1.07M5.80M2.54M801.00K918.00K
Change in Accounts Receivable6.91M3.54M-3.73M-8.83M-6.66M-3.82M
Change in Inventory-893.00K-395.00K3.15M-1.10M-2.59M-3.44M
Change in Accounts Payable1.62M-1.75M-1.99M2.03M-1.97M276.00K
Change in Unearned Revenue307.00K-175.00K-843.00K-989.00K-1.16M215.00K
Change in Other Net Operating Assets1.10M5.36M-3.40M-5.21M7.26M-630.00K
Operating Cash Flow-10.31M-20.37M-31.00M-32.04M-30.74M-27.98M
Capital Expenditures-944.00K-801.00K-1.47M-2.37M-3.27M-2.35M
Cash Acquisitions-2.55M
Other Investing Activities1.61M1.05M10.00M-7.49M
Investing Cash Flow-919.00K-801.00K-2.41M-1.32M6.73M-9.84M
Long-Term Debt Issued10.00M57.48M25.00M
Long-Term Debt Repaid-211.00K-60.00M-1.20M
Net Debt Issued (Repaid)4.79M9.79M-2.52M23.80M
Issuance of Common Stock16.27M29.03M1.00K1.00K298.00K83.41M
Other Financing Activities-2.36M-2.96M-4.29M-1.10M-91.00K-401.00K
Financing Cash Flow18.70M35.85M-6.81M22.70M207.00K83.01M
Net Cash Flow7.48M14.68M-40.22M-10.66M-23.80M45.18M
Free Cash Flow-11.25M-21.18M-32.46M-34.41M-34.01M-30.34M
Free Cash Flow Margin-7.25%-14.20%-43.35%-48.22%-52.15%-54.84%
Free Cash Flow Per Share-0.16-0.32-1.02-1.20-1.26-1.19
Levered Free Cash Flow345.62K-10.41M-17.61M-20.31M-20.50M-16.35M
Unlevered Free Cash Flow5.92M-5.15M-13.06M-16.92M-17.84M-13.84M
Cash Interest Paid8.02M7.59M6.51M4.79M3.54M3.30M
Change in Working Capital9.06M6.58M-6.81M-14.10M-5.12M-7.40M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization156.97M94.51M89.60M83.91M187.01M117.60M
Enterprise Value224.29M161.29M117.43M88.26M153.00M56.71M
Last Close Price2.061.381.612.906.874.46
PS Ratio1.010.631.201.182.872.13
PB Ratio8.793.602.822.453.281.38
P/TBV Ratio2.803.501.42
EV/Sales Ratio1.451.081.571.242.351.02
Debt / Equity Ratio4.003.442.601.830.700.46
Net Debt / Equity Ratio3.112.372.020.08-0.54-0.64
Net Debt / EBITDA Ratio-3.50-2.25-2.01-0.100.912.06
Net Debt / FCF Ratio-5.99-2.94-1.98-0.080.901.80
Asset Turnover1.171.060.580.610.510.50
Inventory Turnover15.0317.833.262.092.002.27
Quick Ratio1.251.471.444.002.576.63
Current Ratio1.882.021.864.732.987.34
Return on Equity (ROE)-116.10%-134.86%-132.53%-66.17%-52.25%-56.37%
Return on Assets (ROA)-10.55%-13.73%-16.54%-15.39%-17.00%-15.67%
Return on Capital Employed (ROCE)-21.80%-28.00%-31.00%-29.80%-42.00%-22.00%
Earnings Yield-21.19%-41.26%-48.78%-35.98%-19.87%-26.52%
FCF Yield-7.17%-22.41%-36.23%-41.01%-18.19%-25.80%
Buyback Yield / Dilution-42.95%-107.82%-10.73%-6.54%-5.58%-35.27%